EVALUATION OF THE QUALITY OF ALBENDAZOLE-BASED MEDICINES SEIZED ON THE ILLICIT MARKET IN CÔTE D’IVOIRE
Abstract
Introduction Substandard and falsified medicines pose a global threat, particularly in sub-Saharan Africa where approximately 10 % of consumed medicines fall into this category. In Côte d’Ivoire, such products are often sold in open-air street markets. Among these, antiinfectives—especially antiparasitics like albendazole—are commonly encountered. Method This study assessed the quality of albendazole in medicines seized by the Directorate of Narcotics and Drugs Control (DPSD) using the GPHF-Minilab® kit, a portable quality-control tool. Results : Of the 15 samples analyzed, 14 exhibited anomalies on visual inspection, 33 % failed disintegration criteria, and 33 % had an assay of active ingredient outside acceptable limits. These findings highlight public health risks associated with consuming these products and underscore the need to strengthen quality-control measures. They also confirm the value of the GPHF-Minilab® in resource-limited settings.
Downloads
All the articles published in JAPSR are distributed under a creative commons license (CC BY-NC-SA 4.0)
Under this license, you are free to:
- Share- copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt- remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Copyright policy
The journal allows the author(s) to hold the copyright of their work. That means the authors do not need to transfer the copyright of their work to the journal. However, the authors grant JAPSR a license to publish the article and identify itself as the original publisher.
Licensing policy
The journal allows the author(s) to hold the copyright of their work. That means the authors do not need to transfer the copyright of their work to the journal. However, the authors grant JAPSR a license to publish the article and identify itself as the original publisher.
